BioNTech | Investor Presentation Deck | 28 slides

BioNTech · 2022-08
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON

Slide inventory

28
every slide · same image gating as the playbook
01
Slide 1
front_matter
03
Standard pharmaceutical regulatory disclosure slide.other
04
Standard pharmaceutical regulatory disclosure slide.other
05
Standard pharmaceutical safety disclosure slide.other
06
inspire_vision
Open slide detailBeat · ProblemLoop · Golden Circle
07
The slide uses a semi-circular layout to represent the company's strategic pillars.summarize
Open slide detailBeat · ProblemLoop · Golden Circle
08
The slide uses a structured grid layout to categorize key performance indicators.show_traction
Open slide detailLoop · Golden Circle
09
The slide uses a list-based timeline/milestone format to highlight growth across five key areas.show_traction
Open slide detailLoop · Golden Circle
10
The slide highlights organizational scale and diversity metrics as of Dec 31, 2021.other
Open slide detailLoop · Golden Circle
11
The slide uses a structured layout to present four pillars of corporate social responsibility.other
Open slide detailLoop · Golden Circle
12
The slide categorizes partnerships into clinical stage and pre-clinical programs, detailing the nature of the collaboration (e.g., cost/profit share, royalties)cite_precedent
Open slide detailLoop · Golden Circle
13
transition
Open slide detailBeat · SolutionLoop · Golden Circle
14
The diagram uses a hexagonal grid to represent different technology platforms and their development status/origin.present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
15
transition
Open slide detailLoop · Golden Circle
16
Uses a temporal progression layout (Today -> Mid-term -> Long-term).plan_implementation
Open slide detailBeat · Market SizeLoop · Golden Circle
17
Includes product image and key performance metrics.show_traction
Open slide detailBeat · Market SizeLoop · Golden Circle
18
Slide highlights both historical traction (>3.6bn doses) and future growth vectors (label expansion, boosters, next-gen vaccines).show_traction
Open slide detailBeat · Market SizeLoop · Golden Circle
19
The slide uses a two-column layout to contrast the 'why' (medical need) with the 'how' (technologies).summarize
Open slide detailBeat · ProductLoop · Golden Circle
20
The chart uses a horizontal bar representation to indicate the clinical stage of each program.plan_implementation
Open slide detailBeat · ProductLoop · Golden Circle
21
The diagram illustrates a circular, iterative process (flywheel) connecting patient samples and variability to specific drug classes.present_solution
Open slide detailBeat · ProductLoop · Golden Circle
22
The slide uses a hub-and-spoke diagram to show how various modalities converge on patient care.present_solution
Open slide detailBeat · ProductLoop · Golden Circle
23
The slide uses a Gantt-style visualization to show clinical trial phases for various drug candidates.show_traction
Open slide detailBeat · ProductLoop · Golden Circle
24
The slide uses a matrix structure to compare different drug development programs.present_solution
Open slide detailBeat · ProductLoop · Golden Circle
25
transition
Open slide detailBeat · The AskLoop · Golden Circle
26
The slide uses a grouped table structure to categorize milestones by therapeutic area (COVID-19, Infectious Disease, Oncology, Data Updates).plan_implementation
Open slide detailBeat · The AskLoop · Golden Circle
27
The slide uses a column-based layout to categorize strategic initiatives, with a footer highlighting foundational enablers.plan_implementation
Open slide detailBeat · The AskLoop · Golden Circle
28
This is a standard corporate contact/footer slide.front_matter
Open slide detailLoop · Golden Circle